Australian News

Australian news and media publication

The Fourth Collegiate Court in Administrative Matters of the First Circuit recognized that scientific studies in Mexico and the United States already support the emergency application of the vaccine Pfizer-BioNTech against Covid-19 in the age group of five to 11 years of age, so a court ruling could be issued in the coming days.

The Court mentioned that Dr. Francisco Moreno Sánchez, Head of Internal Medicine at the ABC Medical Center and Coordinator of the ABC Medical Center Covid-19 Program, as well as Dr. Joaquín Alejandro Zúñiga Ramos, Director of the Area of National Institute of Respiratory Diseases Ismael Cosío Villegas, issued a favorable opinion to the application of the vaccine in girls and boys from five to 11 years of age.

He highlighted that on November 8, 2021, that collegiate court issued a resolution in the complaint resource 245/2021, request the Faculty of Medicine of the National Autonomous University of Mexico, the National Institute of Respiratory Diseases of the Ministry of Health of the Federal Government and the Federal Commission for the Protection against Sanitary Risks that, within three business days inform if they have scientific studies that support the safety of the application of the Pfizer-BioNTech vaccine against the Sars-CoV-2 virus for the prevention of Covid-19, in the age group of five to eleven years, either with or without pre-existing conditions that increase the risk of severe disease.

It was required that, as of the opinion of October 29, 2021, by which the US FDA authorized emergency use of such a vaccine in the age group of five to 11 years, its application is recommended in a child under six years of age who requested protection.

Given this, there was only a response from INER and Dr. Francisco Moreno, so they do not have all the opinions.

However, he stressed that the opinions already issued are based on an exhaustive review of the available data from the clinical trial of the use of the Pfizer-BioNTech Covid-19 vaccine, in children between the ages of five and 11 by a committee made up of a internationally recognized group of experts, for which “they are considered sufficient in order to issue the corresponding resolution, while is based on evidence published at the time, which are serious and of high scientific quality”.

The Tribal said that this matter “is related to the protection of the fundamental right to health of a minor, whose resolution should be privileged, also taking into account that it is a notorious fact that the Omicron variant of the SARS virus is currently circulating. -CoV-2, which has been shown to be much more contagious.”

Leave a Reply

Your email address will not be published.